488 related articles for article (PubMed ID: 19105570)
21. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
22. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
23. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
24. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
[TBL] [Abstract][Full Text] [Related]
25. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
[TBL] [Abstract][Full Text] [Related]
26. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
[TBL] [Abstract][Full Text] [Related]
28. CD25+ CD4+ regulatory T-cells in cancer.
Linehan DC; Goedegebuure PS
Immunol Res; 2005; 32(1-3):155-68. PubMed ID: 16106066
[TBL] [Abstract][Full Text] [Related]
29. Control of NK cell functions by CD4+CD25+ regulatory T cells.
Ralainirina N; Poli A; Michel T; Poos L; Andrès E; Hentges F; Zimmer J
J Leukoc Biol; 2007 Jan; 81(1):144-53. PubMed ID: 16959895
[TBL] [Abstract][Full Text] [Related]
30. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
31. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
Saha A; Chatterjee SK
Scand J Immunol; 2010 Feb; 71(2):70-82. PubMed ID: 20384858
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
33. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
34. New strategies for the manipulation of adaptive immune responses.
Bopp T; Radsak M; Schmitt E; Schild H
Cancer Immunol Immunother; 2010 Sep; 59(9):1443-8. PubMed ID: 20361184
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
36. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Parietti V; Monneaux F; Décossas M; Muller S
Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
[TBL] [Abstract][Full Text] [Related]
37. Beta-2 adrenergic receptors increase TREG cell suppression in an OVA-induced allergic asthma mouse model when mice are moderate aerobically exercised.
Dugger KJ; Chrisman T; Sayner SL; Chastain P; Watson K; Estes R
BMC Immunol; 2018 Feb; 19(1):9. PubMed ID: 29452585
[TBL] [Abstract][Full Text] [Related]
38. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells in tumor immunity.
Nishikawa H; Sakaguchi S
Int J Cancer; 2010 Aug; 127(4):759-67. PubMed ID: 20518016
[TBL] [Abstract][Full Text] [Related]
40. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
